Asia Pacific Radioactive Tracer Market Forecast to 2030

Asia Pacific Radioactive Tracer Market Forecast to 2030 – Regional Analysis – by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others), and End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, and Others)

Send Enquiry
Item ID: BMIRE00029110 Category: Tags: , ,

$2,485$3,885

Description

The Asia Pacific radioactive tracer market was valued at US$ 1,615.80 million in 2022 and is expected to reach US$ 6,629.61 million by 2030; it is estimated to grow at a CAGR of 19.3% from 2022 to 2030.

Rising Prevalence of Chronic Diseases fuel the Asia Pacific Radioactive Tracer Market

Increasing aging population, changing social behavior, rising adoption of a sedentary lifestyle, and accelerating urbanization are the key factors boosting the prevalence of obesity and other chronic diseases such as diabetes. Further, studies have long established that genes can cause chronic conditions such as cardiovascular disease (CVD), diabetes, obesity, Alzheimer’s disease (AD), and depression.

CVDs, such as atherosclerosis, angina pectoris, and acute myocardial infarction, caused due to hectic lifestyles have become significant causes of mortality worldwide. As per the data provided by the WHO, CVDs are the predominant cause of death worldwide, recording estimated 17.9 million deaths each year. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are among the major complications associated with diabetes. The disease prevalence will likely increase by nearly 35% during the forecast period.

Thus, an effective examination is a must for properly treating chronic diseases; hence, nuclear substances are used for diagnosis and examination purposes. These nuclear substances are used in diagnostic tests such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) to diagnose chronic diseases such as neurological, cardiovascular, chronic lung, and chronic kidney diseases. the availability of several radiotracer across the globe makes it selection easy depending on the type of disease and its prognosis. Thus, the increasing incidences of chronic diseases are surging the demand for radioactive tracer, positively favoring market expansion.

Asia Pacific Radioactive Tracer Market Overview

The Asia Pacific radioactive tracer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as the development of new research facilities, the rise in the geriatric population and significant evolution of hybrid systems with technological advancement in the field of imaging.

Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Radioactive Tracer Market Segmentation

The Asia Pacific radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Asia Pacific radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the Asia Pacific radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the Asia Pacific radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the Asia Pacific radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the Asia Pacific radioactive tracer market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the Asia Pacific radioactive tracer market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 19.3% CAGR, the Asia Pacific Radioactive Tracer Market is Speculated to be worth US$ 6,629.61 million by 2030, saysthe research team

According tothe research team’ research,, the Asia Pacific radioactive tracer market was valued at US$ 1,615.80 million in 2022 and is expected to reach US$ 6,629.61 million by 2030, registering a CAGR of 19.3% from 2022 to 2030. Rising prevalence of chronic diseases and increasing use of nuclear imaging techniques are the critical factors attributed to the Asia Pacific radioactive tracer market expansion.

One of the primary opportunities within the radioactive trace market in Asia Pacific lies in the healthcare and diagnostics sector. The emerging economies of region such as China, India, Malaysia, Thailand, Indonesia, and Vietnam, are experiencing high growth and development in their healthcare infrastructure. The region’s vast and rapidly growing population, coupled with and increasing focus on healthcare infrastructure development, makes it a fertile ground for the application of radioactive tracers. Despite being highly preventable, cardiovascular disease (CVD) remains the leading cause of mortality in Asia-Pacific. CVD was responsible for an estimated 9.85 million fatalities in SEARO and WPRO in 2019, accounting for 45% of all NCD deaths in these regions. Furthermore, after CVD, cancer is the second biggest cause of mortality in the Asia-Pacific area. In 2019, cancer was responsible for an estimated 5 million deaths (or 24% of total NCD fatalities) in Asia-Pacific. Furthermore, there were 821.8 million newly diagnosed neurological illnesses globally in 2019: 227 million in the WHO South-East Asia region and 178.6 million in the WHO Western Pacific region. Radioactive tracers play a significant role in diagnostic imaging techniques such as Positron Emission Tomography (PET) and single Phonton Emission Computed Tomography (SPECT). As Asian countries advance their healthcare systems, there is rising demand for precise and early disease detection. Radioactive tracers, which allow for the visualization of molecular and cellular processes within the body, are instrumental in detecting various medical conditions, including cancer, cardiovascular diseases, and neurological disorders. They offer the advantage of early diagnosis and staging, leading to more effective treatment and improved patient outcomes. Moreover, the increasing awareness among both healthcare professionals and the general public about the benefits of nuclear medicine and molecular imaging is driving the demand for radioactive tracers. This trend is further supported by a growing middle-class population with greater access to healthcare services. Thus, the radioactive tracer market in “region’s name” is poised to experience substantial growth as it becomes an integral component of advanced medical diagnostics and patient care.

On the contrary, short shelf-life of radioactive tracer hurdles the growth of Asia Pacific radioactive tracer market.

Based on tracer type, the Asia Pacific radioactive tracer market is categorized into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held 62.1% market share in 2022, amassing US$ 1,002.62 million. It is projected to garner US$ 3,885.24 million by 2030 to expand at 18.5% CAGR during 2022–2030.

Based on test type, the Asia Pacific radioactive tracer market is categorized into PET, SPECT, and others. The SPECT segment held 44.6% share of Asia Pacific radioactive tracer market in 2022, amassing US$ 720.14 million. It is projected to garner US$ 2,917.97 million by 2030 to expand at 19.1% CAGR during 2022–2030.

Based on end user, the Asia Pacific radioactive tracer market is categorized into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held 70.2% share of Asia Pacific radioactive tracer market in 2022, amassing US$ 1,134.15 million. It is projected to garner US$ 4,658.68 million by 2030 to expand at 19.3% CAGR during 2022–2030.

Based on application, the Asia Pacific radioactive tracer market is categorized into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held 61.0% share of Asia Pacific radioactive tracer market in 2022, amassing US$ 985.25 million. It is projected to garner US$ 3932.21 million by 2030 to expand at 18.9% CAGR during 2022–2030.

Based on country, the Asia Pacific radioactive tracer market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.3% share of Asia Pacific radioactive tracer market in 2022. It was assessed at US$ 472.62 million in 2022 and is likely to hit US$ 1,912.64 million by 2030, exhibiting a CAGR of 19.1% during 2022–2030.

Key players operating in the Asia Pacific radioactive tracer market are Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, General Electric Co, and IBA Radiopharma Solutions, among others.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Radioactive Tracer Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Rising Prevalence of Chronic Diseases
4.1.2 Increasing Use of Nuclear Imaging Techniques
4.2 Market Restraints
4.2.1 Short Shelf-Life of Radioactive Tracer
4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
4.3 Market Opportunities
4.3.1 Presence of Emerging Economies and Growing Population
4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
4.4 Future Trends
4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
4.5 Impact Analysis:
5. Radioactive Tracer Market – Asia Pacific Market Analysis
5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 – by Tracer Types
6.1 Overview
6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
6.3 Technetium 99m and TC-97m
6.3.1 Overview
6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Iodine 131
6.4.1 Overview
6.4.2 Iodine 131: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Iron 59
6.5.1 Overview
6.5.2 Iron 59: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Lutetium- 171
6.6.1 Overview
6.6.2 Lutetium- 171: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.7 RB82 and ammonia N-13
6.7.1 Overview
6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Scandium 46
6.8.1 Overview
6.8.2 Scandium 46: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Seaborgium-269
6.9.1 Overview
6.9.2 Seaborgium-269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.10 Hassium -269
6.10.1 Overview
6.10.2 Hassium -269: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.11 Gallium Citrate GA 67
6.11.1 Overview
6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.12 PSMA GA68
6.12.1 Overview
6.12.2 PSMA GA68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.13 FDDNP (F-18) and FDOPA (f-18)
6.13.1 Overview
6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.14 Phosphorus 32 and Chromium -51
6.14.1 Overview
6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.15 Thallium-201
6.15.1 Overview
6.15.2 Thallium-201: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.16 F-18 FDG
6.16.1 Overview
6.16.2 F-18 FDG: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.17 F-18 FAPI
6.17.1 Overview
6.17.2 F-18 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.18 GA 68 FAPI
6.18.1 Overview
6.18.2 GA 68 FAPI: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.19 F-18 PSMA
6.19.1 Overview
6.19.2 F-18 PSMA: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
6.20.1 Overview
6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
6.21 Others
6.21.1 Overview
6.21.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 – by Test Type
7.1 Overview
7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 PET
7.3.1 Overview
7.3.2 PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.4 SPECT
7.4.1 Overview
7.4.2 SPECT: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 – by Application.
8.1 Overview
8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Oncology
8.3.1 Overview
8.3.2 Oncology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Pulmonary
8.4.1 Overview
8.4.2 Pulmonary: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
8.5.1 Overview
8.5.2 Neurology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Radioactive Tracer Market – Country Analysis
10.1 Asia Pacific Radioactive Tracer Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Asia Pacific Radioactive Tracer Market by Country
10.1.2.1 China
10.1.2.1.1 Overview
10.1.2.1.2 China Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1.3 China Radioactive Tracer Market, by Tracer Types
10.1.2.1.4 China Radioactive Tracer Market, by Test Type
10.1.2.1.5 China Radioactive Tracer Market, by Application
10.1.2.1.6 China Radioactive Tracer Market, by End-User
10.1.2.2 Japan
10.1.2.2.1 Overview
10.1.2.2.2 Japan Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 Japan Radioactive Tracer Market, by Tracer Types
10.1.2.2.4 Japan Radioactive Tracer Market, by Test Type
10.1.2.2.5 Japan Radioactive Tracer Market, by Application
10.1.2.2.6 Japan Radioactive Tracer Market, by End-User
10.1.2.3 India
10.1.2.3.1 Overview
10.1.2.3.2 India Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 India Radioactive Tracer Market, by Tracer Types
10.1.2.3.4 India Radioactive Tracer Market, by Test Type
10.1.2.3.5 India Radioactive Tracer Market, by Application
10.1.2.3.6 India Radioactive Tracer Market, by End-User
10.1.2.4 Australia
10.1.2.4.1 Overview
10.1.2.4.2 Australia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.4.3 Australia Radioactive Tracer Market, by Tracer Types
10.1.2.4.4 Australia Radioactive Tracer Market, by Test Type
10.1.2.4.5 Australia Radioactive Tracer Market, by Application
10.1.2.4.6 Australia Radioactive Tracer Market, by End-User
10.1.2.5 South Korea
10.1.2.5.1 Overview
10.1.2.5.2 South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 South Korea Radioactive Tracer Market, by Tracer Type
10.1.2.5.4 South Korea Radioactive Tracer Market, by Test Type
10.1.2.5.5 South Korea Radioactive Tracer Market, by Application
10.1.2.5.6 South Korea Radioactive Tracer Market, by End-User
10.1.2.6 Rest of Asia Pacific
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Rest of Asia Pacific Radioactive Tracer Market, by Tracer Types
10.1.2.6.4 Rest of Asia Pacific Radioactive Tracer Market, by Test Type
10.1.2.6.5 Rest of Asia Pacific Radioactive Tracer Market, by Application
10.1.2.6.6 Rest of Asia Pacific Radioactive Tracer Market, by End-User
11. Radioactive Tracer Market Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Radioactive Tracer Market, Key Company Profiles
12.1 Rotem Industries Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Invicro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Cardinal Health Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Newcastle University
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Curium
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 General Electric Co
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 IBA Radiopharma Solutions
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Radioactive Tracer Market Segmentation
Table 2. Principal Radionuclides Used in Radioactive Tracer
Table 3. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 4. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 5. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 6. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 7. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 8. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 9. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 10. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 11. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 12. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 13. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 14. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 15. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Tracer Types
Table 16. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 17. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Application
Table 18. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – End-User
Table 19. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Type
Table 20. South Korea Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) – Test Type
Table 21. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 22. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 23. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Tracer Types
Table 24. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Test Type
Table 25. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 26. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) – End-User
Table 27. Organic Developments Done by Companies
Table 28. Inorganic Developments Done by Companies
Table 29. Glossary of Terms, Asia Pacific Radioactive Tracer Market

LIST OF FIGURES

Figure 1. Asia Pacific Radioactive Tracer Market Segmentation, By Country
Figure 2. Asia Pacific Radioactive Tracer Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Radioactive Tracer Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Asia Pacific Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
Figure 6. Technetium 99m and TC-97m: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Iodine 131: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Iron 59: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Lutetium- 171: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. RB82 and ammonia N-13: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Scandium 46: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Seaborgium-269: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Hassium -269: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Gallium Citrate GA 67: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. PSMA GA68: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. FDDNP (F-18) and FDOPA (f-18): Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Phosphorus 32 and Chromium -51: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Thallium-201: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. F-18 FDG: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. F-18 FAPI: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. GA 68 FAPI: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. F-18 PSMA: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Asia Pacific Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
Figure 26. PET: Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. SPECT: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Asia Pacific Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
Figure 30. Oncology: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pulmonary: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Neurology: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. Cardiology: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Others: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Asia Pacific Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
Figure 36. Hospitals and Clinics: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Diagnostic Centers: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Academic and Research Institutes: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Others: Asia Pacific Radioactive Tracer Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Asia Pacific Radioactive Tracer Market, By Country, 2022 ($Mn)
Figure 41. Asia Pacific Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
Figure 42. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 43. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 44. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 45. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
Figure 46. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)

The List of Companies – Asia Pacific Radioactive Tracer Market

– Rotem Industries Ltd
– Invicro LLC
– Cardinal Health Inc
– Newcastle University
– Novartis AG
– Curium
– General Electric Co
– IBA Radiopharma Solutions

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific Radioactive Tracer Market Forecast to 2030”